Medical Research Council (MRC) Cancer and Genome Integrity PhD Programme 2019
PhD
In Dundee
Description
-
Type
PhD
-
Location
Dundee (Scotland)
-
Duration
4 Years
-
Start date
Different dates available
Defects in DNA replication or DNA repair can lead to mutations and other genomic alterations that give rise to cancers, and consequently tumours tend to have a high degree of genome instability. Understanding the molecular mechanisms involved in DNA replication and repair, therefore, may pave the way for new treatments for cancer. Furthermore, many of the frontline chemotherapy drugs used to treat cancer act by inducing DNA damage or perturbing DNA replication. Therefore, the efficacy of these therapies depends on our understanding of the mechanisms that cells use to sense and process DNA lesions and DNA replication defects.
Facilities
Location
Start date
Start date
About this course
aim is to train the research leaders of tomorrow, and we provide support and training at every stage of the PhD, in a world class research institute that benefits from core funding from the MRC.
Reviews
This centre's achievements
All courses are up to date
The average rating is higher than 3.7
More than 50 reviews in the last 12 months
This centre has featured on Emagister for 14 years
Subjects
- Medical
- Medical Research
- Medical training
- DNA
- Life Sciences
- DNA damage
- DNA Replication
- DNA repair
- Disease
- Treatments
Course programme
The 4-year PhD programme has two main themes: DNA replication and DNA repair. Karim Labib’s lab studies the eukaryotic replisome that is assembled and disassembled during every cell cycle, to ensure that the chromosomes are duplicated just once. Karim’s group focuses on multiple ubiquitylation pathways that mediate replisome disassembly during S-phase and mitosis, preserving genome integrity in ways that are just starting to be unravelled. John Rouse’s lab focuses on the molecular mechanisms underlying the signaling and repair of DNA damage, especially those that perturb DNA replication, with emphasis on the control of these mechanisms by phosphorylation and ubiquitylation. John’s lab is particularly keen to understand how derailment of DNA repair causes disease, and in developing anti-tumour strategies based on inhibition of DNA repair.
Medical Research Council (MRC) Cancer and Genome Integrity PhD Programme 2019